Biochemical bone markers in patients with multiple myeloma

Clinica Chimica Acta

Volumn 253, Issue 1-2, 1996, Pages 61-77

  Nawawi, Hapizah ^a   Samson, Diana ^b   Apperley, Jane ^b   Girgis, Samia ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Biochemical bone markers; Multiple myeloma

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; CALCIUM; CREATININE; DEOXYPYRIDINOLINE; OSTEOCALCIN; PROCOLLAGEN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; MULTIPLE MYELOMA; OSTEOLYSIS; PRIORITY JOURNAL; REMISSION; URINALYSIS;

EID: 0030607122     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(96)06334-6     Document Type: Article

References (32)

1. [1] Kyle RA, Jowsey J, Kelly PJ, Multiple myeloma bone disease: the comparative effect of sodium fluoride and calcium carbonate or placebo. N Engl J Med 1975b;293:1334-1338.
2. [2] Kyle RA. Multiple myeloma: a review of 869 cases. Mayo Clin Proc 1975a;50:29-40.
3. [3] Valentine-Opran A, Charbon S, Meunier P, Edouard C, Arlot M. Quantitative histology of myeloma-induced bone changes. Br J Haematol 1982;52:805-810.
4. [4] Mundy G, Luben R, Raisz L, Oppenheim J, Buell D. Bone resorbing activity in supernatants from lymphoid cell lines. N Engl J Med 1974;290:867-871.
5. [5] Mundy O, Raisz L, Cooper R, Schechter G, Salmon S. Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med 1974;291:1041-1045.
6. [6] Evans C, Galasko C, Ward C. Does myeloma secrete an osteoclast inhibiting factor? J Bone Joint Surg 1989;71:288.
7. [7] Carter A, Merchov S, Silivan-Draxler I, Tatarsky I. The role of interleukin-1 and tumour necrosis factor-alpha in human multiple myeloma. Br J Haematol 1990;74: 424.
8. [8] Lichtenstein A, Berenson J, Norman D, Chang MP, Carlile A. Production of cytokines by marrow cells obtained from patients with multiple myeloma. Blood 1989;74:1266.
9. [9] Bataille R, Klein B, Jourdan M, Rossi J, Durie BGM. Spontaneous secretion of tumour necrosis factor beta by human myeloma cell lines. Cancer 1989b;63:877.
10. [10] Kawano M, Yamamoto I, Iwato K. IL-1β rather than lymphotoxin as the major bone resorbing activator in human multiple myeloma. Blood 1989;73:1646.
11. [11] Yamamoto I, Kawano M, Sone T et al. Production of interleukin-1 beta, a potent bone resorbing cytokine, by cultured human myeloma cells. Cancer Res 1989;49: 4242-4246.
12. 1):PA169a.
13. 1): PA523a.
14. [14] Garret IR, Dallas SL, Bonewald BF et al. Evidence for bidirectional interactions between osteoclasts and myeloma cells. J Bone Miner Res 1995;10(Suppl. 1):S195.
15. [15] Moss DW. Acid phosphatases. In: Bergmeyer HU, ed. Methods of enzymatic analysis. Weinheim: Verlag Chemie, 1984;96-101.
16. [16] Tietz W, Burtis C, Ervin K, Petitclerc CJ, Rinker AD, Zygowicz E. Progress in the development of a recommended method for alkaline phosphatase activity measurements. Clin Chem 1980;26:1023.
17. [17] Bessey OA, Lowry OH, Brock MJ. A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. J Biol Chem 1946;164:321-329.
18. [18] Jaffe MZ. Ueber den niederschlag, welchen pikrinsaure in normalem ham erzeugt and ueber eine neue reaction des kreatinins. Z Physiol Chem 1886;10:391-400.
19. [19] Chasson AL, Grady HT, Stanley MA. Determination of creatinine by means of automatic chemical analysis. Am J Clin Pathol 1961;35:83.
20. [20] Gitelman HJ. An improved automated procedure for the determination of calcium in biochemical specimen. Anal Biochem 1967;18:521-531.
21. [21] Kessler G, Wolfman M. An automated procedure for the determination of calcium and phosphorus. Clin Chem 1964;10:686-703.
22. [22] Bataille R, Chappard D, Marcelli C. Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease. J Clin Oncol 1989a;7:1909.
23. [23] Elomaa I, Virkkunen P, Risteli L, Risteli J. Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma. Br J Cancer 1992;66:337.
24. [24] Roux C, Ravaud P, Cohen-Solal M et al. Biologic, histologic and densitometric effects of oral risedronate on bone in patients with multiple myeloma. Bone 1994;15: 41-49.
25. [25] Hassager C, Jensen LT, Johansen JS et al. The carboxy-terminal propeptide of type I collagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones. Metabolism 1991;40:205-208.
26. [26] Duda RL, O'Brian JF, Katzmann JA, Peterson JM, Riggs BL. Concurrent assays of circulating bone Gla protein and bone alkaline phosphatase: Effects of sex, age and metabolic bone disease. J Clin Endocrinol Metab 1988;66:951-957.
27. [27] Owen TA, Aronow M, Shalhoub V et al. Progressive development of the rat osteoblast phenotype: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of bone extracellular matrix. J Cell Physiol 1990;143:420-430.
28. [28] Price PA, Williamson MK, Lothringer JW. Origin of the vitamin K-dependant protein found in plasma and its clearance by the kidney and bone. J Biol Chem 1981;256:12760-12766.
29. [29] Tibi L, Chhabra SC, Sweeting VM, Winney RJ, Smith AF. Multiple forms of alkaline phosphatase in plasma of haemodialysis patients. Clin Chem 1991;37:815-820.
30. [30] Malluche HH, Faugee MC, Fanti P, Price PA. Plasma levels of bone Gla protein reflect bone formation in patients on chronic maintenance dialysis. Kidney Int 1984;26:869-874.
31. [31] Lau K-HW, Onishi T, Wergedal JE, Singer FR, Baylink DJ. Characterisation and assay of tartrate resistant acid phosphatase activity in serum: potential use to assess bone resorption. Clin Chem 1987;33:458-462.
32. [32] Nordin BEC, Need AG, Morris HA, Horowitz M. Sodium, calcium and osteoporosis. In: Burckhardt R, Heaney RP, eds. Nutritional aspects of osteoporosis, Serono Symposium. New York: Raven Press, 1991;85:279-293.